GlassScriptPhysician profile
Kenneth Q Wu
NPI 1952632143
$19,687.67
in general payments reported to CMS, 2019-2025
63 companies · $5,304 in 2025
The $5,304 reported for 2025 was more than what 91% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,495 · 2020: $1,366 · 2021: $2,437 · 2022: $2,688 · 2023: $2,082 · 2024: $4,314 · 2025: $5,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,796 · Consulting Fee: $4,000 · Travel and Lodging: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,796.42 |
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $1,903.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $5,903.74 | 2024-2025 | Trigger-Flex |
| Abbott Laboratories | $4,751.59 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $2,487.30 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Tersera Therapeutics LLC | $600.69 | 2019-2025 | Prialt |
| Abbvie INC. | $540.32 | 2021-2025 | Botox |
| Indivior INC. | $474.61 | 2019-2025 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $390.43 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $319.20 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $317.72 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Arbor Pharmaceuticals, INC. | $299.16 | 2019-2021 | |
| Vgi Medical, LLC | $285.93 | 2022 | |
| Medtronic USA, INC. | $252.31 | 2019-2020 | |
| Pfizer INC. | $199.10 | 2019-2025 | |
| Azurity Pharmaceuticals, INC. | $178.17 | 2023-2025 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $156.27 | 2019-2024 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $151.74 | 2020-2024 | Senza |
| Mdd US Operations, LLC | $142.96 | 2019-2020 | |
| Amgen INC. | $138.57 | 2020-2022 | |
| Spinal Simplicity, LLC | $131.24 | 2021 | |
| Merz Pharmaceuticals, LLC | $121.94 | 2021-2022 | |
| Merz North America, INC. | $107.46 | 2019-2020 | |
| Vertos Medical, INC. | $106.26 | 2022-2023 | Mild Device Kit |
| Horizon Therapeutics Plc | $104.98 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $92.27 | 2019-2021 | |
| Almatica Pharma LLC | $76.87 | 2021 | |
| Nalu Medical, INC. | $69.54 | 2024-2025 | Nalu Neurostimulation System |
| Pacira Therapeutics, INC. | $67.62 | 2019 | |
| Relievant Medsystems, INC. | $66.85 | 2021 | |
| Orexo US, INC. | $65.63 | 2019-2020 | |
| Ibsa Pharma INC. | $61.87 | 2020-2023 | Tirosint, Licart |
| Alkermes, INC. | $61.33 | 2019-2020 | |
| Spr Therapeutics, INC | $59.91 | 2020-2025 | Sprint Pns System |
| Masimo Corporation | $58.55 | 2023-2024 | Patient Safetynet System |
| Mml US, INC. | $58.34 | 2023 | Reactiv8 |
| Biotronik Nro, INC. | $52.64 | 2024 | Prospera |
| Biotissue Holdings INC. | $48.72 | 2021 | |
| Redhill Biopharma INC. | $45.51 | 2021 | |
| Grt US Holding, INC. | $44.29 | 2021-2022 | |
| Stimwave Technologies Incorporated | $39.04 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $37.69 | 2023 | Exparel, Zilretta, Iovera |
| Curonix LLC | $37.67 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $34.60 | 2022-2024 | Painteq |
| Lilly USA, LLC | $34.52 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.38 | 2022 | |
| Intrinsic Therapeutics | $28.57 | 2025 | Barricaid Acd (Annular Closure Device) |
| Averitas Pharma INC. | $26.32 | 2024 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $26.08 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.83 | 2024 | |
| Forte Bio-Pharma LLC | $23.83 | 2022 | |
| Stryker Corporation | $23.17 | 2025 | Mild Device Kit |
| Globus Medical, INC. | $22.22 | 2025 | Senza |
| Impel Pharmaceuticals LLC | $22.09 | 2025 | Trudhesa |
| Si-Bone, INC. | $21.72 | 2023 | |
| Tonix Medicines, INC. | $18.64 | 2025 | Tonmya |
| Bioventus LLC | $18.38 | 2019 | |
| Titan Pharmaceuticals, INC. | $18.04 | 2019 | |
| Elutia, INC. | $17.88 | 2019 | |
| Uswm, LLC | $17.07 | 2021 | |
| Saluda Medical Americas, INC. | $16.60 | 2023 | Evoke Scs |
| Shionogi INC | $16.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.13 | 2023 | Seglentis |
| Allergan, INC. | $14.07 | 2020 | |
| Hydrocision, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.